Lauren Amable
Impact in
- Sensory Systems top 2%
- Hearing, Cochlea, Tinnitus, Genetics
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 5
- Hedgehog Signaling Pathway Studies 4
- Metabolism, Diabetes, and Cancer 2
- Biochemical and Molecular Research 2
- Enzyme function and inhibition 2
- DNA Repair Mechanisms 2
- Oncology 6
- Cancer-related Molecular Pathways 2
- Co-authors
- Matthew D. Hall (2 shared papers)Lisa L. Cunningham (1 shared paper)Katharine Fernandez (1 shared paper)Andrew Breglio (1 shared paper)Aaron E. Rusheen (1 shared paper)Katie Spielbauer (1 shared paper)Richard E. Honkanen (6 shared papers)Lalita A. Shevde (3 shared papers)
- Journals
- Cancer Research (2 papers)Clinical Cancer Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Oncology Reports (1 paper)Journal of the American Chemical Society (1 paper)
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
Lauren Amable
18 papers receiving 1.3k citations
Lauren Amable's Hit Papers
Peers
Comparison fields: 5 of 102
- Sensory Systems 174
- Cancer Research 238
- Oncology 391
- Molecular Biology 735
- Biotechnology 71
Countries citing papers authored by Lauren Amable
This map shows the geographic impact of Lauren Amable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Amable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Amable more than expected).
Fields of papers citing papers by Lauren Amable
This network shows the impact of papers produced by Lauren Amable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Amable. The network helps show where Lauren Amable may publish in the future.
Co-authors
The 25 scholars most cited alongside Lauren Amable, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cisplatin resistance and opportunities for precision medicine Hit paper breakdown → | 2016 | 485 |
| 2 | Cisplatin is retained in the cochlea indefinitely following chemotherapy Hit paper breakdown → | 2017 | 290 |
| 3 | 2003 | 87 | |
| 4 | 2017 | 65 | |
| 5 | 2012 | 53 | |
| 6 | 2008 | 49 | |
| 7 | 2009 | 48 | |
| 8 | 2016 | 47 | |
| 9 | 2006 | 46 | |
| 10 | 2011 | 31 | |
| 11 | 2016 | 28 | |
| 12 | 2014 | 19 | |
| 13 | 2012 | 16 | |
| 14 | 2013 | 11 | |
| 15 | 2019 | 10 | |
| 16 | 2012 | 6 | |
| 17 | 2006 | 2 | |
| 18 | 2016 | 1 | |
| 19 | 2012 | 0 |
About Lauren Amable
Lauren Amable is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Biotechnology, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Hedgehog Signaling Pathway Studies (4 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Biochemical and Molecular Research (2 papers), Enzyme function and inhibition (2 papers), Cancer-related Molecular Pathways (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Sensory Systems (174 citations), Cancer Research (238 citations), Oncology (391 citations), Molecular Biology (735 citations) and Biotechnology (71 citations). Lauren Amable has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Matthew D. Hall, Lisa L. Cunningham, Katharine Fernandez, Andrew Breglio, Aaron E. Rusheen, Katie Spielbauer, Richard E. Honkanen, Lalita A. Shevde, Elaine Gavin and Mark R. Swingle. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Journal of Pharmacology and Experimental Therapeutics, Oncology Reports and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.